Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Cancer Vaccines

Geron Corporation Reports 2007 Third Quarter Financial Results and Events

For the third quarter of 2007, the company reported a net loss of $12.8 million, or $(0.17) per share, compared to $8.1 million, or $(0.12) per share, for the comparable 2006 period. Net loss applicable to common stockholders for the first nine months of 2007 was $29.3 million, or $(0.40) per share, compared to $18.2 million, or $(0.28) per share, for the comparable 2006 period.

Revenues for the third quarter of 2007 were $1.1 million, compared to $723,000 for the comparable 2006 period. Revenues for the first nine months of 2007 were $2.9...

• View Other Issues of Vaccine Weekly
  
• View Other NewsRx Publications